While most public attention has focused on this new ability to prevent heart attacks, researchers have also made important progress in speeding the recovery of patients who survive heart attacks.
To put it another way: Of the 2,127,000 American who died that year, more than one in three died of heart disease.
The most important thing we can do is teach patients in advance about the value of early treatment, he says.
We have to know how to respond quickly, and we have to have the courage to use these drugs in the absence of definitive diagnosis, says Dr. Burton Sobel of Washington University in St. Louis, a pioneer in the testing of the clot-dissolvers.
